Immunosuppressive strategies in transplantation.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  The Lancet

• Publication date

  1999-03-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(98)07493-5PMID 10199367
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycophenolate Mofetil

  2012cited by this paper
• Human renal allograft rejection: molecular characterization.

  1998cited by this paper
• Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group.

  1998cited by this paper
• Late blockade of T cell costimulation interrupts progression of experimental chronic allograft rejection.

  1998cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• Interleukin-2-Receptor Blockade With Daclizumab to Prevent Acute Rejection in Renal Transplantation

  1998cited by this paper
• Safety and tolerability of cyclosporine and cyclosporine microemulsion during 18 months of follow-up in stable renal transplant recipients: a report of the Canadian Neoral Renal Study Group.

  1998cited by this paper
• A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

  1998cited by this paper
• Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group.

  1998cited by this paper
• Relationship between maintenance dose of cyclosporine and long-term kidney graft survival. Collaborative Transplant Study.

  1998cited by this paper
• A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.

  1998cited by this paper
• Homeostasis and self-tolerance in the immune system: turning lymphocytes off.

  1998cited by this paper
• PRELIMINARY RESULTS OF THE COMBINED USE OF A HUMANIZED ANTI-IL-2R?? MONOCLONAL ANTIBODY, DACLIZUMAB (DZB), AND MYCOPHENOLATE MOFETIL (MMF) WITHOUT CALCINEURIN INHIBITORS IN RENAL TRANSPLANTATION

  1998cited by this paper
• Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens.

  1998cited by this paper
• The role of T-cell costimulatory activation pathways in transplant rejection.

  1998cited by this paper
• A Blinded, Long-term, Randomized Multicenter Study Of Mycophenolate Mofetil In Cadaveric Renal Transplantation: Results at Three Years1,2

  1998cited by this paper
• In vivo expression of transforming growth factor-beta1 in humans: stimulation by cyclosporine.

  1998cited by this paper
• Cyclosporine microemulsion increases drug exposure and reduces acute rejection without incremental toxicity in de novo renal transplantation. International Sandimmun Neoral Study Group.

  1998cited by this paper
• Mycophenolate mofetil for the treatment of a first acute renal allograft rejection

  1998cited by this paper
• Central role for CD40/CD40 ligand (CD154) interactions in transplant rejection.

  1998cited by this paper
• Muromonab-Cd3 and Antithymocyte Globulin in Renal Transplantation

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group.

  1997cited by this paper
• A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.

  1997cited by this paper
• Sirolimus, a New, Potent Immunosuppressive Agent

  1997cited by this paper
• A novel approach to the treatment of chronic allograft nephropathy.

  1997cited by this paper
• Murine OKT4A immunosuppression in cadaver donor renal allograft recipients: a cooperative clinical trials in transplantation pilot study. Cooperative Clinical Trials in Transplantation Research Group.

  1997cited by this paper
• Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation.

  1997cited by this paper
• CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates.

  1997cited by this paper
• Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

  1997cited by this paper
• Peptide-mediated immunosuppression.

  1997cited by this paper
• Tacrolimus rescue therapy for renal allograft rejection--five-year experience.

  1997cited by this paper
• Decreased cytotoxic activity of natural killer cells in kidney allograft recipients treated with human HLA-derived peptide.

  1997cited by this paper
• The prospects for xenotransplantation of the kidney

  1997cited by this paper
• Immunosuppressive effects of human CTLA4Ig in a non-human primate model of allogeneic pancreatic islet transplantation.

  1997cited by this paper
• T-cell costimulatory blockade in experimental chronic cardiac allograft rejection: effects of cyclosporine and donor antigen.

  1997cited by this paper
• Indirect allorecognition of major histocompatibility complex allopeptides in human renal transplant recipients with chronic graft dysfunction.

  1997cited by this paper
• A Comparison Of Tacrolimus (fk506) And Cyclosporine For Immunosuppression After Cadaveric Renal Transplantation1

  1997cited by this paper
• Gene therapy and allotransplantation.

  1997cited by this paper
• Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group.

  1997cited by this paper
• Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients.

  1997cited by this paper
• Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection - A report of the European Tacrolimus Multicenter Renal Study Group

  1997cited by this paper
• Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.

  1997cited by this paper
• Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients

  1997cited by this paper
• Tacrolimus (FK506) and sirolimus (rapamycin) in combination are not antagonistic but produce extended graft survival in cardiac transplantation in the rat.

  1997cited by this paper
• CD28 costimulation prevents cell death during primary T cell activation.

  1996cited by this paper
• Prevention and reversal of renal allograft rejection by antibody against CD45RB

  1996cited by this paper
• Structure of the complex between human T-cell receptor, viral peptide and HLA-A2

  1996cited by this paper
• Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

  1996cited by this paper
• Chronic cardiac rejection in the LEW to F344 rat model. Blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis.

  1996cited by this paper
• CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism.

  1996cited by this paper
• Short course single agent therapy with an LFA-3-IgG1 fusion protein prolongs primate cardiac allograft survival.

  1996cited by this paper
• Chronic cyclosporine nephropathy: the Achilles' heel of immunosuppressive therapy.

  1996cited by this paper
• Variable oral absorption of cyclosporine. A biopharmaceutical risk factor for chronic renal allograft rejection.

  1996cited by this paper
• Post-transplant hyperlipidemia: mechanisms and management.

  1996cited by this paper
• A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.

  1996cited by this paper
• Novel immunotherapeutic strategies using MHC derived peptides.

  1996cited by this paper
• A randomized multicenter trial comparing leukocyte function-associated antigen-1 monoclonal antibody with rabbit antithymocyte globulin as induction treatment in first kidney transplantations.

  1996cited by this paper
• Anti-CD4 MoAb therapy in kidney transplantation--a pilot study in early prophylaxis of rejection.

  1996cited by this paper
• The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients.

  1996cited by this paper
• Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression.

  1996cited by this paper
• HLA matching.

  1996cited by this paper
• Immunosuppressive therapy abrogates unresponsiveness to renal allograft induced by thymic recognition of donor antigens.

  1995cited by this paper
• HLA matching in renal transplantation.

  1995cited by this paper
• Anti-CD45 monoclonal antibody perfusion of human renal allografts prior to transplantation. A safety and immunohistological study. CD45 Study Group.

  1995cited by this paper
• Rapamycin inhibits transplant vasculopathy in long-surviving rat heart allografts.

  1995cited by this paper
• Effects of RS61443 on functional and morphological changes in chronically rejecting rat kidney allografts.

  1995cited by this paper
• ANTI‐CD45 MONOCLONAL ANTIBODY PERFUSION OF HUMAN RENAL ALLOGRAFTS PRIOR TO TRANSPLANTATION A SAFETY AND IMMUNOHISTOLOGICAL STUDY

  1995cited by this paper
• Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.

  1995cited by this paper
• Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids

  1995cited by this paper
• Medical progress : renal transplantation

  1994cited by this paper
• The role of CD40 in the regulation of humoral and cell-mediated immunity.

  1994cited by this paper
• Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. European FK506 Multicentre Liver Study Group.

  1994cited by this paper
• Effect of the maintenance immunosuppressive drug regimen on kidney transplant outcome.

  1994cited by this paper
• Renal transplantation.

  1994cited by this paper
• Mechanisms of T cell recognition of alloantigen. The role of peptides.

  1994cited by this paper
• HLA matching in renal transplantation.

  1994cited by this paper
• Long-term efficacy and safety of cyclosporine in renal-transplant recipients.

  1994cited by this paper
• Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation.

  1993cited by this paper
• A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients.

  1993cited by this paper
• CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM

  1993cited by this paper
• The role of the CD28 receptor during T cell responses to antigen.

  1993cited by this paper
• Contribution of direct and indirect recognition pathways to T cell alloreactivity

  1993cited by this paper
• RS‐61443 (Mycophenolate Mofetil) A Multicenter Study for Refractory Kidney Transplant Rejection

  1992cited by this paper
• A randomized prospective trial of anti-Tac monoclonal antibody in human renal transplantation.

  1991cited by this paper
• CTLA-4 is a second receptor for the B cell activation antigen B7

  1991cited by this paper
• Transplantation tolerance.

  1991cited by this paper
• Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.

  1990cited by this paper
• T-lymphocyte-antigen interactions in transplant rejection.

  1990cited by this paper
• Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients.

  1990cited by this paper
• Cyclosporine.

  1989cited by this paper
• Drug therapy: cyclosporine

  1989cited by this paper
• TRANSMEMBRANE SIGNALLING VIA THE T CELL ANTIGEN RECEPTOR HETERODIMER AND THE CD2 ANTIGEN

  1989cited by this paper

• Practice variation in the use of steroid-sparing therapies in childhood steroid-sensitive nephrotic syndrome: results from a prospective cohort study

  2025cites this paper
• Preventing the rejection of skin allografts by immunomodulatory and regenerative effects of exosomes derived from bone marrow mesenchymal stem cells in mice

  2025cites this paper
• Therapeutic drug monitoring in kidney and liver transplantation: current advances and future directions

  2024cites this paper
• CXCR2 Activated JAK3/STAT3 Signaling Pathway Exacerbating Hepatotoxicity Associated with Tacrolimus

  2024cites this paper
• Effects of switching from twice-daily tacrolimus to once-daily extended-release meltdose tacrolimus on cellular immune response

  2024cites this paper
• Enhancing cellular immunotherapies in cancer by engineering selective therapeutic resistance

  2024cites this paper
• Effects of CYP3A5 Genetic Polymorphisms on the Weight-adjusted through Concentration of Sirolimus in Renal Transplant Recipients: A Systematic Review and Meta-analysis.

  2024cites this paper
• Continuous immunosuppression is required for suppressing immune responses to xenografts in non-human primate brains

  2024cites this paper
• Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study

  2024cites this paper
• Landscape of the immune infiltration and identification of molecular diagnostic markers associated with immune cells in patients with kidney transplantation

  2024cites this paper
• Extracellular Vesicles: The Future of Diagnosis in Solid Organ Transplantation?

  2023cites this paper
• Recent advances in the development of bioartificial pancreas using 3D bioprinting for the treatment of type 1 diabetes: a review

  2023cites this paper
• Recommendations for living donor kidney transplantation.

  2022cites this paper
• Antithymocyte Globulin Inhibits CD8+ T Cell Effector Functions via the Paracrine Induction of PDL-1 on Monocytes

  2022cites this paper
• Recomendaciones para el trasplante renal de donante vivo

  2022cites this paper
• Long-term survival in non-human primates of stem cell-derived, MHC-unmatched corneal epithelial cell sheets

  2022cites this paper
• Optimization of initial dose regimen of tacrolimus in paediatric lung transplant recipients based on Monte Carlo simulation

  2022cites this paper
• Wasabi Component 6-(Methylsulfinyl)hexly Isothiocyanate and Derivatives Improve the Survival of Skin Allografts

  2022cites this paper
• Population pharmacokinetics models of sirolimus in renal transplant patients: A systematic review.

  2021cites this paper
• O USO DE IMUNOSSUPRESSORES: EM PACIENTES ADULTOS DE TRANSPLANTE RENAL

  2021cites this paper
• Machine learning‐based method for tacrolimus dose predictions in Chinese kidney transplant perioperative patients

  2021cites this paper
• Pediatric Kidney Transplantation

  2021cites this paper
• Future strategies to improve short- and long-term outcomes of renal transplantation in dogs

  2021cites this paper
• PET-CT in Infection and Inflammation

  2021cites this paper
• A primer for managing cardiac transplant patients in the emergency department setting.

  2021cites this paper
• Identification of Biomarkers for Predicting Allograft Rejection following Kidney Transplantation Based on the Weighted Gene Coexpression Network Analysis

  2021cites this paper
• Clinical efficacy and safety of different tacrolimus concentrations for the treatment of patients with idiopathic membranous nephropathy

  2021cites this paper
• Use of immunosuppression in non-transplant hepatology.

  2021cites this paper
• Hypertension in cardiac transplant recipients: tackling a new face of an old foe.

  2020cites this paper
• PET-CT in the Organ Transplantation

  2020cites this paper
• Application of PLGA nano/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection

  2020cites this paper
• Calcineurin Inhibition Causes α2δ-1–Mediated Tonic Activation of Synaptic NMDA Receptors and Pain Hypersensitivity

  2020cites this paper
• Diagnosis and Treatment

  2020cites this paper
• Efficacy and safety of tacrolimus in Chinese lupus nephritis patients : a meta-analysis

  2019cites this paper
• The past, present, and future of costimulation blockade in organ transplantation.

  2019cites this paper
• Formulation of the Scope and Key Questions of the Guideline Recommendations for Immunosuppressive Treatment in Kidney Transplantation

  2019cites this paper
• Tacrolimus ameliorates proteinuria in Chinese pediatric lupus nephritis patients

  2019influential citation
• Can tissue engineering produce bioartificial organs for transplantation?

  2019cites this paper
• Bioprinting an Artificial Pancreas for Type 1 Diabetes

  2019cites this paper
• Efficacy and safety of tacrolimus in treating pediatric refractory nephrotic syndrome: a meta-analysis

  2018cites this paper
• LCK as a Potential Therapeutic Target for Acute Rejection after Kidney Transplantation: A Bioinformatics Clue

  2018cites this paper
• HLA in transplantation

  2018cites this paper
• Posterior Reversible Encephalopathy in Nephrotic Syndrome: Case Report

  2018cites this paper
• Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients

  2018cites this paper
• Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real‐world study

  2018cites this paper
• Clinicopathologic Relevance of Vascular Changes Associated with Transplant Glomerulopathy Secondary to Chronic Antibody-mediated Rejection in the Renal Allograft

  2018cites this paper
• Correlation of Pretransplant Trough Tacrolimus Level with Early Acute Rejection In Live Donor Renal Transplantation- A Prospective Study

  2018cites this paper
• Gene expression profiles for predicting antibody‑mediated kidney allograft rejection: Analysis of GEO datasets.

  2018cites this paper
• El trasplante pulmonar en la fibrosis quística y la influencia de la circulación extracorpórea

  2018cites this paper
• Saprochaete capitata (Geotrichum capitatum), an emerging fungal infection in kidney transplant recipients

  2018cites this paper
• Prostatic abscess as a cause of pyrexia of unknown origin in posttransplant recipient detected on F18 Fluorodeoxyglucose positron emission tomography/computed tomography

  2018cites this paper
• Practical Pearls About Current Rheumatic Medications.

  2018cites this paper
• Tacrolimus improves proteinuria remission in adults with cyclosporine A‐resistant or ‐dependent minimal change disease

  2017cites this paper
• Recent progress in the use and tracking of transplanted islets as a personalized treatment for type 1 diabetes

  2017cites this paper
• Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy

  2017cites this paper
• Combinatorial drug delivery approaches for immunomodulation

  2017cites this paper
• Immunomodulation, Acute Renal Failure, and Complications of Basiliximab Use After Liver Transplantation: Analysis of 114 Patients and Literature Review.

  2017cites this paper
• Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.

  2017cites this paper
• Monitoring of peripheral blood cluster of differentiation 4+ adenosine triphosphate activity and CYP3A5 genotype to determine the pharmacokinetics, clinical effects and complications of tacrolimus in patients with autoimmune diseases.

  2017cites this paper
• Sirolimus-Induced Combined Posterior Reversible Encephalopathy Syndrome and Lymphocytic Pneumonitis in a Renal Transplant Recipient: Case Report and Review of the Literature.

  2017cites this paper
• Chapter 62 – Immunosuppressive Drugs

  2017cites this paper
• Allogeneic ovarian transplantation using immunomodulator preimplantation factor (PIF) as monotherapy restored ovarian function in olive baboon

  2017cites this paper
• Use of Anti-Thymocyte Globulin for Induction Therapy in Cardiac Transplantation: A Review.

  2017cites this paper
• Acute right heart failure caused by tacrolimus after renal transplantation: Serial observation by speckle tracking and Doppler echocardiography

  2017cites this paper
• Study of the Influence of a Combination of Pharmacogenetic Variables on Tacrolimus Exposure: A Population Pharmacokinetic Approach

  2017cites this paper
• Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients.

  2017cites this paper
• Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation.

  2016cites this paper
• Tacrolimus for children with refractory nephrotic syndrome: a one-year prospective, multicenter, and open-label study of Tacrobell®, a generic formula

  2016cites this paper
• Eight‐year results of the Spiesser study, a randomized trial comparing de novo sirolimus and cyclosporine in renal transplantation

  2016cites this paper
• Design, synthesis, and evaluation of 4,6-diaminonicotinamide derivatives as novel and potent immunomodulators targeting JAK3.

  2016cites this paper
• The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection

  2016cites this paper
• CyclosporinReview of the Pharmacokinetic Properties, Clinical Efficacy and Tolerability of a Microemulsion-Based Formulation (Neoral ® ) 1 in Organ Transplantation

  2016cites this paper
• Induction of Donor-Specific Tolerance with Vascularized Bone Marrow Transplantation

  2016cites this paper
• Global and CMV-specific Immune Assays to Predict Clinical Outcomes and Inform Clinical Practice in Solid Organ Transplant Recipients

  2016cites this paper
• A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia

  2016cites this paper
• From the Department of Molecular Medicine and Surgery Karolinska Institutet, Stockholm, Sweden INVESTIGATION OF HEPATOCYTE SIGNALING PATHWAYS IN CHRONIC KIDNEY DISEASE. CLINICAL AND EXPERIMENTAL STUDIES

  2016cites this paper
• Combined Anti‐CD154/CTLA4Ig Costimulation Blockade‐Based Therapy Induces Donor‐Specific Tolerance to Vascularized Osteomyocutaneous Allografts

  2016cites this paper
• Chapter 6 – General and ocular pharmacology

  2016cites this paper
• The emergency medicine approach to transplant complications.

  2016cites this paper
• Böbrek naklinde kullanılan immünsüpresif tedaviler

  2016cites this paper
• Synthesis and evaluation of 1H-pyrrolo[2,3-b]pyridine derivatives as novel immunomodulators targeting Janus kinase 3.

  2015cites this paper
• The Use of an IL-1 Receptor Antagonist Peptide to Control Inflammation in the Treatment of Corneal Limbal Epithelial Stem Cell Deficiency

  2015cites this paper
• Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study

  2015cites this paper
• Comparison of Basiliximab and Anti‐Thymocyte Globulin as Induction Therapy in Pediatric Heart Transplantation: A Survival Analysis

  2015cites this paper
• LONG-TERM OUTCOME AFTER PEDIATRIC

  2015cites this paper
• TACROLIMUS DRUG LEVEL AND RESPONSE TO TREATMENT IN IDIOPATHIC CHILDHOOD STEROID RESISTANT NEPHROTIC SYNDROME.

  2015cites this paper
• Central modulation of cyclosporine-induced hypertension

  2015cites this paper
• Peritumoral dermis of squamous cell carcinomas in renal transplant recipients contains less CD11c+ myeloid dendritic cells and FoxP3+ T cells compared to immunocompetent controls

  2015cites this paper
• Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3.

  2015cites this paper
• Prevalence of Metabolic Syndrome in Organ Transplantation: A Review of the Literature

  2015cites this paper
• Fox smell abrogates the effect of herbal odor to prolong mouse cardiac allograft survival

  2014cites this paper
• Assessing ciclosporin in the treatment of leprosy reactions : evidence from a randomized controlled trial and other studies

  2014cites this paper
• Graft and Patient Survival

  2014cites this paper
• Advanced stem cell delivery systems for the treatment of corneal epithelial limbal stem cell deficiency

  2014cites this paper
• Protective Vaccination against Papillomavirus-Induced Skin Tumors under Immunocompetent and Immunosuppressive Conditions: A Preclinical Study Using a Natural Outbred Animal Model

  2014cites this paper
• Impact of cytochrome P450 3A5 polymorphism in graft livers on the frequency of acute cellular rejection in living-donor liver transplantation

  2014cites this paper
• Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity.

  2014cites this paper
• Extended-Release Tacrolimus: A Review of Its Use in De Novo Kidney Transplantation

  2014cites this paper
• Cancer risk of immunosuppressants in manufacturing.

  2014cites this paper
• Overview of Renal Transplantation in the United States

  2014cites this paper